A股異動 | 秀強股份(300160.SZ)續漲逾5% 暫五日連升累漲約40%
格隆匯6月12日丨秀強股份(300160.SZ)今日續漲,本週已五日連升累漲約40%,現報8.47元,漲5.22%,暫成交7.7億元,最新總市值52億元。秀強股份昨晚發公告稱,預計2020年新能源汽車充電樁玻璃產品銷售收入佔全年銷售收入比例較小。公司目前尚未完成特斯拉太陽能屋頂玻璃的工程認證,能否接到特斯拉太陽能屋頂訂單尚存在不確定性,公司太陽能屋頂玻璃產品的客户僅有特斯拉一家,單一客户依賴性較大,如果未來特斯拉該項目市場拓展未達預期或市場供求發生變化,可能會造成公司新產品產能利用率不達預期,對公司經營業績產生不利影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.